SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-090366
Filing Date
2020-08-04
Accepted
2020-08-04 17:08:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2026299d2_s3.htm S-3 173850
2 EXHIBIT 5.1 tm2026299d2_ex5-1.htm EX-5.1 6084
3 EXHIBIT 23.1 tm2026299d2_ex23-1.htm EX-23.1 2422
4 GRAPHIC tm2026299d2_ex5-1img01.jpg GRAPHIC 4900
  Complete submission text file 0001104659-20-090366.txt   190361
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-240361 | Film No.: 201074177
SIC: 2836 Biological Products, (No Diagnostic Substances)